![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 31, 2021 8:24:16 AM
Per fintel the short volume as a percent of traded volume collapsed in the last few days to very low levels, so the shorts are leaning far away from this very steep move which suggests they know something , as normally they’d aggressively lean into it. The sector has not run up near as much as CLVR this week (unlike the February run up which was sector wide) so I just don’t think this is due to a possible decriminalization bill finally coming to the Senate floor. If this were a newsletter or analyst recommendation I could certainly see a one or two day run up but nothing like the activity we’ve seen the last week. Oversold rallies rarely go from oversold relative strength and money flow to almost overbought in barely a week on no news announcement and without similarly strong moves within the sector. Earlier in the week when I saw GME and AMC were again on a tear, it made me wonder if this run up in CLVR was the wall street bets group piling in (I have not been able to verify it). So, having ruled out most possibilities, if it’s not the WSB group then I think a very significant announcement is forthcoming possibly even a buyout or merger of some sort. Adding to the mystery, the warrants are at $2.55 on Fridays close but they were well over $3 the last time the commons were in this low $12 range, so either the warrants are undervalued and will catch up or this reduced spread differential is telling a bigger story...that the $11.50 strike is keeping a tight leash on the warrants pending forthcoming news. . Curaleaf just bought EMMAC for 286M to position itself for EU growth in coming years. So what would a company pay for CLVR to be able to position itself in a similar manner in the EU plus gain huge exposure to the entire Latam region? Anything less than 500M would be a really bad deal for investors imo. Just spit balling here but this latest activity is way out of the norm since its despac.
Recent CLVR News
- Clever Leaves Announces Voluntary Delisting and SEC Deregistration • GlobeNewswire Inc. • 04/26/2024 08:10:00 PM
- Clever Leaves Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 04/01/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:01:46 PM
- Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia • GlobeNewswire Inc. • 02/13/2024 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/01/2024 10:13:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:11:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:04:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:03:21 PM
- Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:19:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:13:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:11:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 10:00:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/09/2023 09:09:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:04:18 PM
- Clever Leaves Reports Third Quarter 2023 Results • GlobeNewswire Inc. • 11/09/2023 09:01:00 PM
- Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET • GlobeNewswire Inc. • 11/02/2023 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/23/2023 08:52:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:15:43 PM
- Clever Leaves Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 09/13/2023 12:30:00 PM
- Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis Company • GlobeNewswire Inc. • 08/29/2023 01:00:00 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 08/25/2023 08:08:15 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/24/2023 01:10:48 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM